Evidence map›Paper›PMID 34031561›Full record

ArticleNature chemistry2021

SARS-CoV-2 simulations go exascale to predict dramatic spike opening and cryptic pockets across the proteome.

Maxwell I Zimmerman, Justin R Porter, Michael D Ward, Sukrit Singh, Neha Vithani, Artur Meller, Upasana L Mallimadugula, Catherine E Kuhn, Jonathan H Borowsky, Rafal P Wiewiora and 8 more

Open access · bronzeAbstract read
In one paragraph

Article in Nature chemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 158 papers.

0numbers the graph read from it
0cells of the map it votes in
158citing papers in PubMed
20.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

158 citing papers in PubMed, 292 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Tyrosine kinases sample unique activation ensembles.bioRxiv : the preprint server for biology · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Computational Ligand-Binding Site Prediction.Advances in experimental medicine and biology · 2026
    Review
  18. Article
  19. Article
  20. Review

98 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 2 countries.

Maxwell I ZimmermanDepartment of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St Louis, MO, USA.
Justin R PorterDepartment of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St Louis, MO, USA.ORCID http://orcid.org/0000-0002-0340-951X
Michael D WardDepartment of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St Louis, MO, USA.
Sukrit SinghDepartment of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St Louis, MO, USA.ORCID http://orcid.org/0000-0003-1914-4955
Neha VithaniDepartment of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St Louis, MO, USA.
Artur MellerDepartment of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St Louis, MO, USA.
Upasana L MallimadugulaDepartment of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St Louis, MO, USA.
Catherine E KuhnDepartment of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St Louis, MO, USA.
Jonathan H BorowskyDepartment of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St Louis, MO, USA.ORCID http://orcid.org/0000-0002-0761-3585
Rafal P WiewioraTri-Institutional PhD Program in Chemical Biology, Memorial Sloan Kettering Cancer Center, NY, New York, USA.
Matthew F D HurleyDepartment of Chemistry, Temple University, Philadelphia, PA, USA.
Aoife M HarbisonDepartment of Chemistry and Hamilton Institute, Maynooth University, Maynooth, Ireland.
Carl A FogartyDepartment of Chemistry and Hamilton Institute, Maynooth University, Maynooth, Ireland.ORCID http://orcid.org/0000-0001-5333-8206
Joseph E CofflandCauldron Development LLC, Petaluma, CA, USA.
Elisa FaddaDepartment of Chemistry and Hamilton Institute, Maynooth University, Maynooth, Ireland.
Vincent A VoelzDepartment of Chemistry, Temple University, Philadelphia, PA, USA.
John D ChoderaComputational and Systems Biology Program, Sloan Kettering Institute, NY, New York, USA.ORCID http://orcid.org/0000-0003-0542-119X
Gregory R BowmanDepartment of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St Louis, MO, USA. g.bowman@wustl.edu.ORCID http://orcid.org/0000-0002-2083-4892
Washington University in St. Louis · USNational University of Ireland, Maynooth · IETemple University · USKettering University · USMemorial Sloan Kettering Cancer Center · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
Project 4 (Genetic modifiers for APOE-associated Alzheimer's disease pathogenesis)U19AG069701 · NIA · MAYO CLINIC JACKSONVILLE · PI Takahisa Kanekiyo · 2021 to 2026
$42.0M
Markov State Model approaches for folding, binding and designR01GM123296 · NIGMS · TEMPLE UNIV OF THE COMMONWEALTH · PI VOELZ, VINCENT · 2017 to 2025
$3.1M
MSMs, adaptive sampling, and data sharing on the cloudR01GM124007 · NIGMS · WASHINGTON UNIVERSITY · PI BOWMAN, GREGORY · 2017 to 2021
$2.0M
The role of reorganization energy in achieving selective kinase inhibition"R01GM121505 · NIGMS · SLOAN-KETTERING INST CAN RESEARCH · PI CHODERA, JOHN DAMON · 2017 to 2021
$1.8M
Structural basis for ApoE4-induced Alzheimer's diseaseRF1AG067194 · NIA · WASHINGTON UNIVERSITY · PI BOWMAN, GREGORY · 2021 to 2021
$1.8M
Computer Cluster for Computational Biology and BiophysicsS10OD020095 · OD · TEMPLE UNIV OF THE COMMONWEALTH · PI LEVY, RONALD · 2015 to 2015
$442k
Physics-based precision medicine: computationally phenotyping myosin isoforms and cardiomyopathy mutationsF30HL146052 · NHLBI · WASHINGTON UNIVERSITY · PI PORTER, JUSTIN ROY · 2019 to 2021
$130k
NCI NIH HHS P30 CA008748NHLBI NIH HHS F30 HL146052NIA NIH HHS RF1 AG067194NIA NIH HHS U19 AG069701NIGMS NIH HHS R01 GM121505NIGMS NIH HHS R01 GM123296NIGMS NIH HHS R01 GM124007NIH HHS S10 OD020095
6 · The paper itself

Abstract

SARS-CoV-2 has intricate mechanisms for initiating infection, immune evasion/suppression and replication that depend on the structure and dynamics of its constituent proteins. Many protein structures have been solved, but far less is known about their relevant conformational changes. To address this challenge, over a million citizen scientists banded together through the Folding@home distributed computing project to create the first exascale computer and simulate 0.1 seconds of the viral proteome. Our adaptive sampling simulations predict dramatic opening of the apo spike complex, far beyond that seen experimentally, explaining and predicting the existence of 'cryptic' epitopes. Different spike variants modulate the probabilities of open versus closed structures, balancing receptor binding and immune evasion. We also discover dramatic conformational changes across the proteome, which reveal over 50 'cryptic' pockets that expand targeting options for the design of antivirals. All data and models are freely available online, providing a quantitative structural atlas.

Indexed as

Binding SitesComputer SimulationCOVID-19HumansMolecular Dynamics SimulationProtein BindingProtein ConformationProteomeSARS-CoV-2Spike Glycoprotein, CoronavirusProteomeSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2

Identifiers

PMID34031561
PMCPMC8249329
OpenAlexW3164917922

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.